112 related articles for article (PubMed ID: 1319617)
1. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
Kazama Y; Koide T
Thromb Haemost; 1992 Jan; 67(1):50-5. PubMed ID: 1319617
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
3. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin.
Mori S; Shinohata R; Renbutsu M; Takahashi HK; Fang YI; Yamaoka K; Okamoto M; Yamamoto I; Nishibori M
Cell Tissue Res; 2003 Jun; 312(3):353-9. PubMed ID: 12764609
[TBL] [Abstract][Full Text] [Related]
4. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
5. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
Poon IK; Olsson AK; Hulett MD; Parish CR
Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
[TBL] [Abstract][Full Text] [Related]
6. Histidine-rich glycoprotein plus zinc to neutralize heparin.
Fu CL; Horn MK
J Lab Clin Med; 2002 Apr; 139(4):211-7. PubMed ID: 12024108
[TBL] [Abstract][Full Text] [Related]
7. Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate.
Cella G; Boeri G; Saggiorato G; Paolini R; Luzzatto G; Terribile VI
Angiology; 1992 Jan; 43(1):59-62. PubMed ID: 1554154
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
Shen L; Villoutreix BO; Dahlbäck B
Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
10. Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2+.
Sun W; Eriksson AS; Schedin-Weiss S
Biochemistry; 2009 Feb; 48(5):1094-8. PubMed ID: 19140680
[TBL] [Abstract][Full Text] [Related]
11. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
13. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers.
Bendetowicz AV; Kai H; Knebel R; Caplain H; Hemker HC; Lindhout T; Béguin S
Thromb Haemost; 1994 Nov; 72(5):705-12. PubMed ID: 7900078
[TBL] [Abstract][Full Text] [Related]
14. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
Neese LL; Wolfe CA; Church FC
Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
[TBL] [Abstract][Full Text] [Related]
15. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
Van Walderveen MC; Berry LR; Chan AK
J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
[TBL] [Abstract][Full Text] [Related]
16. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of activated protein C by platelets.
Jane SM; Mitchell CA; Hau L; Salem HH
J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
[TBL] [Abstract][Full Text] [Related]
18. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Tollefsen DM; Pestka CA
J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
Padilla A; Gray E; Pepper DS; Barrowcliffe TW
Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]